Arcus Operating Income from 2010 to 2024

RCUS Stock

USD 17.40 0.02 0.11%

Arcus Biosciences Operating Income yearly trend continues to be comparatively stable with very little volatility. Operating Income is likely to outpace its year average in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Arcus Biosciences generates from its operations. View All Fundamentals

Operating Income

First Reported

2016-12-31

Previous Quarter

-106 M

Current Value

-105 M

Quarterly Volatility

66.5 M

Covid

Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 41 M, Interest Income of 43 M or Depreciation And Amortization of 6.1 M, as well as many indicators such as Price To Sales Ratio of 11.48, Dividend Yield of 0.0 or PTB Ratio of 3.39. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.

Check out the analysis of Arcus Biosciences Correlation against competitors.

For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Latest Arcus Biosciences' Operating Income Growth Pattern

Below is the plot of the Operating Income of Arcus Biosciences over the last few years. Operating Income is the amount of profit realized from Arcus Biosciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Arcus Biosciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Arcus Biosciences' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcus Biosciences' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Arcus Operating Income Regression Statistics

	Arithmetic Mean	(89,151,333)
	Geometric Mean	50,497,506
	Coefficient Of Variation	(138.53)
	Mean Deviation	94,750,622
	Median	(18,182,000)
	Standard Deviation	123,501,189
	Sample Variance	15252.5T
	Range	394.2M
	R-Value	(0.72)
	Mean Square Error	7872.2T
	R-Squared	0.52
	Significance	0
	Slope	(19,928,193)
	Total Sum of Squares	213535.6T

Arcus Operating Income History

	2024	-323 M
	2023	-340 M
	2022	-280 M
	2021	54.2 M
	2020	-124.2 M
	2019	-88.7 M
	2018	-54.9 M

Other Fundumenentals of Arcus Biosciences

Non Operating Income Net Other

Arcus Biosciences Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Capital Surpluse	Total Liab	Long Term Investments	Total Current Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Short Term Debt	Capital Stock
Total Assets		0.99	0.93	-0.21	-0.73	0.85	0.67	0.86	0.9	0.99	0.95	0.93	0.59	0.66	0.98	-0.03	0.98	0.99	0.71	0.59
Total Stockholder Equity	0.99		0.92	-0.23	-0.67	0.81	0.7	0.83	0.88	0.95	0.91	0.91	0.5	0.57	0.96	0.03	1.0	0.99	0.78	0.5
Net Tangible Assets	0.93	0.92		-0.37	-0.88	0.83	0.53	0.86	0.99	0.92	0.85	0.9	0.72	0.77	0.94	0.09	0.92	0.93	0.69	0.71
Net Debt	-0.21	-0.23	-0.37		0.58	-0.58	0.39	-0.56	-0.45	-0.2	0.05	-0.48	-0.47	-0.45	-0.38	0.14	-0.21	-0.21	-0.03	-0.47
Retained Earnings	-0.73	-0.67	-0.88	0.58		-0.82	-0.13	-0.83	-0.93	-0.76	-0.63	-0.82	-0.92	-0.94	-0.79	-0.01	-0.66	-0.69	-0.32	-0.92
Accounts Payable	0.85	0.81	0.83	-0.58	-0.82		0.2	0.98	0.86	0.86	0.7	0.97	0.74	0.75	0.92	-0.14	0.81	0.83	0.38	0.74
Net Receivables	0.67	0.7	0.53	0.39	-0.13	0.2		0.21	0.42	0.62	0.76	0.35	-0.04	0.06	0.55	-0.02	0.71	0.7	0.87	-0.05
Short Term Investments	0.86	0.83	0.86	-0.56	-0.83	0.98	0.21		0.89	0.87	0.71	0.99	0.74	0.76	0.92	0.03	0.82	0.83	0.38	0.74
Capital Surpluse	0.9	0.88	0.99	-0.45	-0.93	0.86	0.42	0.89		0.9	0.8	0.91	0.78	0.83	0.93	0.09	0.88	0.89	0.6	0.78
Total Liab	0.99	0.95	0.92	-0.2	-0.76	0.86	0.62	0.87	0.9		0.96	0.92	0.66	0.72	0.97	-0.08	0.95	0.97	0.63	0.66
Long Term Investments	0.95	0.91	0.85	0.05	-0.63	0.7	0.76	0.71	0.8	0.96		0.8	0.56	0.63	0.89	-0.08	0.92	0.93	0.66	0.56
Total Current Assets	0.93	0.91	0.9	-0.48	-0.82	0.97	0.35	0.99	0.91	0.92	0.8		0.72	0.74	0.96	-0.01	0.89	0.91	0.49	0.72
Common Stock	0.59	0.5	0.72	-0.47	-0.92	0.74	-0.04	0.74	0.78	0.66	0.56	0.72		0.99	0.65	-0.12	0.51	0.55	0.03	1.0
Property Plant Equipment	0.66	0.57	0.77	-0.45	-0.94	0.75	0.06	0.76	0.83	0.72	0.63	0.74	0.99		0.7	-0.12	0.58	0.61	0.12	0.99
Current Deferred Revenue	0.98	0.96	0.94	-0.38	-0.79	0.92	0.55	0.92	0.93	0.97	0.89	0.96	0.65	0.7		-0.11	0.96	0.97	0.67	0.65
Deferred Long Term Liab	-0.03	0.03	0.09	0.14	-0.01	-0.14	-0.02	0.03	0.09	-0.08	-0.08	-0.01	-0.12	-0.12	-0.11		-0.03	-0.06	0.05	-0.13
Net Invested Capital	0.98	1.0	0.92	-0.21	-0.66	0.81	0.71	0.82	0.88	0.95	0.92	0.89	0.51	0.58	0.96	-0.03		1.0	0.79	0.51
Net Working Capital	0.99	0.99	0.93	-0.21	-0.69	0.83	0.7	0.83	0.89	0.97	0.93	0.91	0.55	0.61	0.97	-0.06	1.0		0.76	0.55
Short Term Debt	0.71	0.78	0.69	-0.03	-0.32	0.38	0.87	0.38	0.6	0.63	0.66	0.49	0.03	0.12	0.67	0.05	0.79	0.76		0.03
Capital Stock	0.59	0.5	0.71	-0.47	-0.92	0.74	-0.05	0.74	0.78	0.66	0.56	0.72	1.0	0.99	0.65	-0.13	0.51	0.55	0.03

Click cells to compare fundamentals

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	-340 M	-323 M
Non Operating Income Net Other	357.3 K	339.4 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Arcus Operating Income from 2010 to 2024

Latest Arcus Biosciences' Operating Income Growth Pattern

Arcus Operating Income Regression Statistics

Arcus Operating Income History

Other Fundumenentals of Arcus Biosciences

Arcus Biosciences Operating Income component correlations

About Arcus Biosciences Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Arcus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY